Published in Nature on March 23, 2000
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut (2006) 9.03
Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev (2006) 7.72
Epidemiology of gastric cancer. World J Gastroenterol (2006) 7.67
Gastric cancer. Lancet (2009) 7.27
Helicobacter pylori persistence: biology and disease. J Clin Invest (2004) 4.75
Inflammation, atrophy, and gastric cancer. J Clin Invest (2007) 4.29
Helicobacter pylori in health and disease. Gastroenterology (2009) 3.84
Activation of beta-catenin by carcinogenic Helicobacter pylori. Proc Natl Acad Sci U S A (2005) 3.52
Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev (2010) 3.41
Coadaptation of Helicobacter pylori and humans: ancient history, modern implications. J Clin Invest (2009) 3.26
Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells. J Exp Med (2001) 2.96
Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J Med Genet (2004) 2.95
Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses. J Clin Invest (2001) 2.70
Helicobacter pylori genetic diversity and risk of human disease. J Clin Invest (2001) 2.58
Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location. Gastroenterology (2009) 2.39
Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori. Nat Rev Microbiol (2013) 2.16
Convergence of IL-1beta and VDR activation pathways in human TLR2/1-induced antimicrobial responses. PLoS One (2009) 2.14
Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors. Cancer Res (2008) 2.08
The importance of interleukin 1beta in Helicobacter pylori associated disease. Gut (2001) 2.02
Aberrant overexpression of IL-15 initiates large granular lymphocyte leukemia through chromosomal instability and DNA hypermethylation. Cancer Cell (2012) 2.01
Comparison of genetic divergence and fitness between two subclones of Helicobacter pylori. Infect Immun (2001) 1.98
Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants. Gut (2002) 1.92
Nature meets nurture: molecular genetics of gastric cancer. Hum Genet (2009) 1.87
Cellular and molecular aspects of gastric cancer. World J Gastroenterol (2006) 1.84
Functional plasticity in the type IV secretion system of Helicobacter pylori. PLoS Pathog (2013) 1.84
Manipulation of rab GTPase function by intracellular bacterial pathogens. Microbiol Mol Biol Rev (2007) 1.82
Carcinogenic bacterial pathogen Helicobacter pylori triggers DNA double-strand breaks and a DNA damage response in its host cells. Proc Natl Acad Sci U S A (2011) 1.81
Role of innate immunity in Helicobacter pylori-induced gastric malignancy. Physiol Rev (2010) 1.73
Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses. Clin Microbiol Rev (2006) 1.73
Intact gram-negative Helicobacter pylori, Helicobacter felis, and Helicobacter hepaticus bacteria activate innate immunity via toll-like receptor 2 but not toll-like receptor 4. Infect Immun (2004) 1.72
Cancer and inflammation: promise for biologic therapy. J Immunother (2010) 1.72
Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Gut (2004) 1.68
2011: the immune hallmarks of cancer. Cancer Immunol Immunother (2011) 1.66
Recent developments in gastroenterology. BMJ (2002) 1.59
A revised annotation and comparative analysis of Helicobacter pylori genomes. Nucleic Acids Res (2003) 1.59
Interleukin-1beta promotes gastric atrophy through suppression of Sonic Hedgehog. Gastroenterology (2009) 1.58
Helicobacter pylori: present status and future prospects in Japan. J Gastroenterol (2007) 1.57
Interleukin-1 receptor antagonist intron 2 variable number of tandem repeats polymorphism and respiratory failure in children with community-acquired pneumonia. Pediatr Crit Care Med (2008) 1.57
The NLRP3 inflammasome in health and disease: the good, the bad and the ugly. Clin Exp Immunol (2011) 1.56
Influence of bile reflux and Helicobacter pylori infection on gastritis in the remnant gastric mucosa after distal gastrectomy. J Gastroenterol (2005) 1.56
TLR2-independent induction and regulation of chronic intestinal inflammation. Eur J Immunol (2010) 1.55
Dual infection with Helicobacter bilis and Helicobacter hepaticus in p-glycoprotein-deficient mdr1a-/- mice results in colitis that progresses to dysplasia. Am J Pathol (2005) 1.51
The role of the purinergic P2X7 receptor in inflammation. J Inflamm (Lond) (2007) 1.50
Gastric cáncer: Overview. Colomb Med (Cali) (2013) 1.49
Retracted A Role for PPARgamma in the Regulation of Cytokines in Immune Cells and Cancer. PPAR Res (2008) 1.48
Helicobacter pylori's unconventional role in health and disease. PLoS Pathog (2009) 1.47
A novel genetic polymorphism of inducible nitric oxide synthase is associated with an increased risk of gastric cancer. World J Gastroenterol (2004) 1.40
Pathobionts of the gastrointestinal microbiota and inflammatory disease. Curr Opin Immunol (2011) 1.39
Interleukin-1β gene variants are associated with QTc interval prolongation following cardiac surgery: a prospective observational study. Can J Anaesth (2016) 1.39
Inflammatory gradient in Barrett's oesophagus: implications for disease complications. Gut (2002) 1.38
In vitro activity of a novel antimicrobial agent, TG44, for treatment of Helicobacter pylori infection. Antimicrob Agents Chemother (2006) 1.36
Accelerated progression of gastritis to dysplasia in the pyloric antrum of TFF2 -/- C57BL6 x Sv129 Helicobacter pylori-infected mice. Am J Pathol (2007) 1.35
Polymorphisms in inflammatory response genes and their association with gastric cancer: A HuGE systematic review and meta-analyses. Am J Epidemiol (2010) 1.35
The cag pathogenicity island of Helicobacter pylori is disrupted in the majority of patient isolates from different human populations. J Clin Microbiol (2004) 1.35
Helicobacter pylori and gastric cancer. Gastric Cancer (2009) 1.34
Helicobacter pylori is invasive and it may be a facultative intracellular organism. Cell Microbiol (2007) 1.33
Helicobacter Pylori associated global gastric cancer burden. Front Biosci (Landmark Ed) (2009) 1.33
Correlation between cag pathogenicity island composition and Helicobacter pylori-associated gastroduodenal disease. Infect Immun (2003) 1.32
Helicobacter pylori in the pathogenesis of gastric cancer and gastric lymphoma. Cancer Lett (2010) 1.31
Biological role of interleukin 1 receptor antagonist isoforms. Ann Rheum Dis (2000) 1.30
Assessment of the toll-like receptor 4 Asp299Gly, Thr399Ile and interleukin-8 -251 polymorphisms in the risk for the development of distal gastric cancer. BMC Cancer (2007) 1.30
Helicobacter pylori virulence factors in gastric carcinogenesis. Cancer Lett (2008) 1.29
Multifactorial etiology of gastric cancer. Methods Mol Biol (2012) 1.29
Field defects in progression to gastrointestinal tract cancers. Cancer Lett (2007) 1.28
Variants associated with common disease are not unusually differentiated in frequency across populations. Am J Hum Genet (2005) 1.28
Pharmacogenetics of antidepressant response. J Psychiatry Neurosci (2011) 1.28
Interleukin-6 promoter haplotypes and interleukin-6 cytokine responses. Shock (2003) 1.27
Family history and the risk of gastric cancer. Br J Cancer (2009) 1.27
Effects of Helicobacter pylori infection on gastric acid secretion and serum gastrin levels in Mongolian gerbils. Gut (2001) 1.27
A dual role for the immune response in a mouse model of inflammation-associated lung cancer. J Clin Invest (2011) 1.25
Survival of metastatic gastric cancer: Significance of age, sex and race/ethnicity. J Gastrointest Oncol (2011) 1.25
Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million US male veterans. Cancer (2010) 1.25
Inducible nitric oxide synthetase genotype and Helicobacter pylori infection affect gastric cancer risk. World J Gastroenterol (2012) 1.22
Association of interleukin 1B gene polymorphism and gastric cancers in high and low prevalence regions in China. Gut (2003) 1.22
DNA methylation as a marker for the past and future. J Gastroenterol (2006) 1.20
Concurrent Helicobacter bilis infection in C57BL/6 mice attenuates proinflammatory H. pylori-induced gastric pathology. Infect Immun (2009) 1.20
The role of the gastrointestinal microbiome in Helicobacter pylori pathogenesis. Gut Microbes (2013) 1.20
Increase in NF-kappaB binding affinity of the variant C allele of the toll-like receptor 9 -1237T/C polymorphism is associated with Helicobacter pylori-induced gastric disease. Infect Immun (2009) 1.19
Tumour-necrosis factor-A polymorphisms and gastric cancer risk: a meta-analysis. Br J Cancer (2008) 1.18
The inflammasome component NLRP3 impairs antitumor vaccine by enhancing the accumulation of tumor-associated myeloid-derived suppressor cells. Cancer Res (2010) 1.18
Genetic variation in the prostate stem cell antigen gene and upper gastrointestinal cancer in white individuals. Gastroenterology (2010) 1.18
Gastric cancer: an infectious disease. Infect Dis Clin North Am (2010) 1.17
Composition and gene expression of the cag pathogenicity island in Helicobacter pylori strains isolated from gastric carcinoma and gastritis patients in Costa Rica. Infect Immun (2001) 1.17
Epidemiological review of gastric cancer in India. Indian J Med Paediatr Oncol (2011) 1.17
Common variants in interleukin-1-Beta gene are associated with intracranial hemorrhage and susceptibility to brain arteriovenous malformation. Cerebrovasc Dis (2008) 1.17
Innate immunity genes influence the severity of acute appendicitis. Ann Surg (2004) 1.16
Genetic variants in inflammation pathway genes and asthma in glioma susceptibility. Neuro Oncol (2010) 1.15
Genomic and epigenetic profiles of gastric cancer: potential diagnostic and therapeutic applications. Surg Today (2010) 1.15
TLR4 and TNF-alpha polymorphisms are associated with an increased risk for severe sepsis following burn injury. J Med Genet (2004) 1.15
Genetic polymorphisms associated with intervertebral disc degeneration. Spine J (2013) 1.15
Helicobacter pylori stimulates dendritic cells to induce interleukin-17 expression from CD4+ T lymphocytes. Infect Immun (2009) 1.15
Helicobacter pylori cag-Pathogenicity island-dependent early immunological response triggers later precancerous gastric changes in Mongolian gerbils. PLoS One (2009) 1.14
Diet, microbial virulence, and Helicobacter pylori-induced gastric cancer. Gut Microbes (2013) 1.13
Role of deletion located between the intermediate and middle regions of the Helicobacter pylori vacA gene in cases of gastroduodenal diseases. J Clin Microbiol (2009) 1.13
Helicobacter pylori Infection and Gastric Adenocarcinoma. US Gastroenterol Hepatol Rev (2011) 1.12
Importance of gastrin in the pathogenesis and treatment of gastric tumors. World J Gastroenterol (2009) 1.12
Vacuolating cytotoxin and variants in Atg16L1 that disrupt autophagy promote Helicobacter pylori infection in humans. Gastroenterology (2012) 1.12
Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science (1990) 16.68
Analysis of variance for gene expression microarray data. J Comput Biol (2000) 16.28
Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA (1991) 11.53
Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med (1996) 10.49
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer (1998) 10.17
Rising incidence of renal cell cancer in the United States. JAMA (1999) 9.57
Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus. Proc Natl Acad Sci U S A (1985) 8.53
The p21 src genes of Harvey and Kirsten sarcoma viruses originate from divergent members of a family of normal vertebrate genes. Nature (1981) 8.44
Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med (1991) 7.52
Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res (1988) 7.30
Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med (1969) 6.54
Theoretical perspectives on the relation between catastrophizing and pain. Clin J Pain (2001) 6.49
A cancer family syndrome in twenty-four kindreds. Cancer Res (1988) 6.39
Genomic heterogeneity of AIDS retroviral isolates from North America and Zaire. Science (1985) 6.31
Effect of adenosine on atrioventricular (AV) conduction. Pacing Clin Electrophysiol (1990) 5.83
The Agricultural Health Study. Environ Health Perspect (1996) 5.72
A Polycomb-group gene regulates homeotic gene expression in Arabidopsis. Nature (1997) 5.65
Analysis of two divergent rat genomic clones homologous to the transforming gene of Harvey murine sarcoma virus. Proc Natl Acad Sci U S A (1981) 5.51
Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials (2000) 5.37
Survival in medically treated patients with homozygous beta-thalassemia. N Engl J Med (1994) 5.32
Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes. Am J Hum Genet (1998) 5.24
Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science (1999) 5.09
CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. Proc Natl Acad Sci U S A (1989) 5.07
Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med (2001) 4.98
Posttranscriptional selection of simian virus 40-specific RNA. J Virol (1975) 4.87
The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med (1996) 4.81
Dual evolutionary origin for the rat genetic sequences of Harvey murine sarcoma virus. J Virol (1980) 4.63
Solid cancers after bone marrow transplantation. N Engl J Med (1997) 4.62
Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst (1993) 4.59
Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias. J Natl Cancer Inst (2000) 4.51
Validation of the United States' version of the World Health Organization Quality of Life (WHOQOL) instrument. J Clin Epidemiol (2000) 4.41
Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood (2000) 4.34
Snuff dipping and oral cancer among women in the southern United States. N Engl J Med (1981) 4.33
Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients. J Natl Cancer Inst (1991) 4.24
Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst (1997) 4.09
Identification of a sarcoma virus-coded phosphoprotein in nonproducer cells transformed by Kirsten or Harvey murine sarcoma virus. Virology (1979) 4.08
Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg (1996) 3.77
Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med (2000) 3.72
Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst (1998) 3.66
Agricultural herbicide use and risk of lymphoma and soft-tissue sarcoma. JAMA (1986) 3.63
Benzene and the dose-related incidence of hematologic neoplasms in China. Chinese Academy of Preventive Medicine--National Cancer Institute Benzene Study Group. J Natl Cancer Inst (1997) 3.61
Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science (1998) 3.60
Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst (1997) 3.57
Unbuffered highly acidic gastric juice exists at the gastroesophageal junction after a meal. Gastroenterology (2001) 3.52
HLA and AIDS: a cautionary tale. Trends Mol Med (2001) 3.51
Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J Immunol (2000) 3.46
Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J Biol Chem (1994) 3.41
Collection of genomic DNA from adults in epidemiological studies by buccal cytobrush and mouthwash. Cancer Epidemiol Biomarkers Prev (2001) 3.40
Risk of cancer in renal-transplant recipients. Lancet (1973) 3.36
Conservation of the regulatory subunit for the Clp ATP-dependent protease in prokaryotes and eukaryotes. Proc Natl Acad Sci U S A (1990) 3.33
Cancer risk in users of calcium channel blockers. Hypertension (1997) 3.30
Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology (1995) 3.28
Second cancers after adjuvant tamoxifen therapy for breast cancer. J Natl Cancer Inst (1996) 3.26
An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res (1998) 3.22
Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology (1997) 3.16
High levels of untreated distress and fatigue in cancer patients. Br J Cancer (2004) 3.15
A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control (2001) 3.13
Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses. Nat Genet (2000) 3.10
Splenectomy and subsequent mortality in veterans of the 1939-45 war. Lancet (1977) 3.05
Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA (1997) 3.00
Clues to cancer etiology from studies of farmers. Scand J Work Environ Health (1992) 2.98
Merkel cell carcinoma and melanoma: etiological similarities and differences. Cancer Epidemiol Biomarkers Prev (1999) 2.97
Alosetron in irritable bowel syndrome. Lancet (2000) 2.94
p21 of Kirsten murine sarcoma virus is thermolabile in a viral mutant temperature sensitive for the maintenance of transformation. J Virol (1979) 2.94
Does concern about missing malignancy justify endoscopy in uncomplicated dyspepsia in patients aged less than 55? Am J Gastroenterol (1999) 2.89
Expression of a polypeptide containing a dipeptide repeat is confined to the insect stage of Trypanosoma brucei. Nature (1987) 2.86
Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst (1997) 2.83
Pathogen-specific loss of host resistance in mice lacking the IFN-gamma-inducible gene IGTP. Proc Natl Acad Sci U S A (2000) 2.80
A scan for linkage disequilibrium across the human genome. Genetics (1999) 2.79
Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst (1996) 2.78
New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS. J Immunol (1999) 2.76
Recent cancer trends in the United States. J Natl Cancer Inst (1995) 2.76
Cell-to-cell spread of HIV-1 occurs within minutes and may not involve the participation of virus particles. Virology (1992) 2.71
Continuing climb in rates of esophageal adenocarcinoma: an update. JAMA (1993) 2.71
ERM proteins in cell adhesion and membrane dynamics. Trends Cell Biol (1999) 2.71
Transfer of the shared epitope through microchimerism in women with rheumatoid arthritis. Arthritis Rheum (2009) 2.69
Established breast cancer risk factors by clinically important tumour characteristics. Br J Cancer (2006) 2.68
The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA (1995) 2.68
45-year follow-up of hepatitis C virus infection in healthy young adults. Ann Intern Med (2000) 2.66
Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer (1999) 2.66
Population attributable risk of renal cell cancer in Minnesota. Am J Epidemiol (1998) 2.65
Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood (1999) 2.65
Intra-abdominal hypertension and the abdominal compartment syndrome. Br J Surg (2004) 2.61
A population-based case-control study of childhood leukemia in Shanghai. Cancer (1988) 2.59
Creutzfeldt-Jakob disease probably acquired from a cadaveric dura mater graft. Case report. J Neurosurg (1988) 2.57
Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. JAMA (1998) 2.55
Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status. Gastroenterology (1999) 2.53
The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N Engl J Med (1989) 2.51
Arsenic and respiratory cancer in man: an occupational study. J Natl Cancer Inst (1969) 2.50
International trends and patterns of primary liver cancer. Int J Cancer (2001) 2.50
Tobacco use and prostate cancer: 26-year follow-up of US veterans. Am J Epidemiol (1991) 2.49